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Evidence-based practice (EBP) is growing in the field 
of Prosthetics & Orthotics (P&O), and its importance is 
emphasized.1–4 Establishing an EBP is considered as highly 
relevant in a time of increasing pressure on health service 
budgets for all health-care branches.5 Rehabilitation research-
ers have been quite successful in proving that multidiscipli-
nary rehabilitation assessments and treatments are effective 
in optimizing the functional recovery after acute injury/dis-
ease and during chronic illness.6–8 At the same time, there is 
mounting awareness of the complexity in establishing a 
coherent evidence base for multidisciplinary rehabilitation: 
that is, in determining, translating and integrating external 
evidence from systematic research on different patients in 
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Abstract
Background: A divide is experienced between producers and users of evidence in prosthetic rehabilitation.
Objective: To discuss the complexity inherent in establishing evidence-based practice in a prosthetic rehabilitation team 
illustrated by the case of prosthetic prescription for elderly dysvascular transfemoral amputee patients.
Study Design: A qualitative research design was used, in which data from multiple sources was triangulated to extract 
themes for discussion.
Methods: This discussion paper draws on empirical material gathered by individual and focus-group interviews with mem-
bers of a prosthetic rehabilitation team, information on technological advancements presented on websites of orthopae-
dic industry, guidelines and literature study.
Results: A prosthetic rehabilitation team needs to deal with lack of evidence, contradictory results, various classification 
systems, diverging interests of different stakeholders and many modifying factors, and all of this in a continuous tech-
nological changing environment. Integrating research designs with different strengths but not sharing the same biases 
may help researchers to deal with the multimorbidity and multifaceted disability of the target group. Articulating clinical 
knowledge, patients’ needs and values in a systematic way provides depth, detail, nuance and context for evidence-based 
practice issues in prosthetic rehabilitation.
Conclusions: Reconsidering the relationship between evidence, technology and rehabilitation practice is an imperative 
shared enterprise for clinicians and researchers. Scientific, clinical and patient-related knowledge are seen as important 
knowledge practices that should inform and strengthen each other.
Clinical relevance
This discussion paper puts the academic clinical debate on evidence-based practice in prosthetics and orthotics in 
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practice are integrated.
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improved and more efficient assessments and treatments for 
rehabilitation settings. This definitely yields for clinicians 
working in prosthetic rehabilitation with lower-limb amputee 
patients.9
In line with Sackett et al.’s10 definition of evidence-
based medicine (EBM), EBP in prosthetic rehabilitation is 
characterized as the process of integrating individual clini-
cal expertise and patient values with the best available evi-
dence from systematic research, in order to provide the best 
clinical care.1–4 This definition comes across as attractive. It 
gives the impression that it is the ‘simple’ task of (rehabili-
tation) clinicians to combine original evidence produced in 
different research settings with their own individual clinical 
expertise including the individual needs of patients to 
whom they wish to give the best treatment. Of course, it is 
not that simple. A number of practical barriers in perform-
ing EBP are to be dealt with, such as lack of high-level 
evidence in P&O, time constraints and workload demands 
experienced by clinicians and finally limited skills, knowl-
edge and resources required to perform EBP.1–4 Researchers 
interested in P&O point variously to limitations in both 
research and practice hindering the evidence-based integra-
tion process. A culture change is plead for, in which clini-
cians in P&O are to be educated as lifelong, self-directed 
learners and are encouraged to pursue relevant clinical 
research themselves.3 In this discussion paper, it will be 
argued and illustrated that the evidence-based integration 
process implied in EBP is an extremely complex task in 
general, and in prosthetic rehabilitation in particular, and 
should therefore be considered as a shared enterprise of 
both clinicians and researchers.
Methods
This discussion paper stems from a broader research pro-
ject aimed at narrowing the experienced divide between 
research and practice in multidisciplinary rehabilitation. 
Inspired by theory-driven programme evaluation,11,12 
participatory action research,9,13,14 and social studies of 
science,15,16 questions about the complexity of EBP are 
addressed from the perspective of rehabilitation clinicians. 
In this discussion paper, the case of prosthetic prescription 
for older dysvascular transfemoral amputee patients is 
explored. The argument presented here draws on the 
following: (1) empirical material gathered by individual 
interviews and a focus-group interview with members of a 
prosthetic rehabilitation team, (2) information on techno-
logical advancements presented on websites of orthopaedic 
industry and the clinical practice guideline for rehabilitation 
of lower-limb amputation and (3) prosthetic rehabilitation 
literature and literature on the research–practice divide.
For the empirical part of the study, first individual 
interviews and a focus-group interview were conducted 
with members of a multidisciplinary prosthetic rehabilita-
tion team in a Dutch rehabilitation centre. The rehabilitation 
centre is part of a university medical centre. Two physiatrists, 
five physical therapists, two occupational therapists and one 
prosthetist participated in the interviews.  All professionals 
provided informed consent. The interviews were recorded 
and transcribed verbally. S.v.T. asked individual respondents 
about the motives behind their actions in prosthetic prescrip-
tion and prosthetic training and about the impact of techno-
logical advancements on their actions. They were also asked 
about the sources they used to keep up to date with techno-
logical advancements. An independent experienced modera-
tor led the focus-group interview on topics that needed to be 
further explored. The prescription of a knee mechanism for 
transfemoral elderly amputee patients was taken as case in 
order to make the discussion more concrete. The moderator 
also gave room for reflections on new topics that arose in the 
efforts of participants to understand each other. Based on 
these interviews, a scene was sketched of clinicians that 
needed to operate in a complex health landscape in order to 
perform EBP.
Second, the websites of two orthopaedic industries (Otto 
Bock and Össur) were explored, as these were used by the 
clinicians to keep up to date with the technological possi-
bilities. The clinical practice guideline for rehabilitation of 
lower-limb amputation17 was also added as a source of 
information for implementation of EBP.
Third, the scientific literature on prosthetic rehabilitation 
and on the research-practice divide collected by our research 
group within the past 10 years was studied to explore the 
scientific context. The literature studies were not conducted 
in a systematic manner, as is required for systematic reviews 
summarizing and critically appraising published evidence 
on certain issues. Indeed, our intention was neither to give 
an overview of the research-practice debate nor to present 
evidence for prosthetic rehabilitation that is methodologi-
cally generalizable. Rather, we wanted to reflect from a sci-
entific point of view on issues and on-going dilemmas the 
rehabilitation clinicians had to face in attempting to work in 
an evidence-based manner and explore promising solution 
directions in the scientific literature.
The themes that emerged from the empirical and scien-
tific material across sources are (1) the methodological com-
plexity in research on elderly amputee patients, (2) the 
impact of technological advancements on evidence-based 
prescription, (3) diverging classification systems in pros-
thetic prescription and (4) additional modifying factors in the 
transfer to individual patients. With this discussion paper, we 
invite both researchers and clinicians to comment on the 
solution directions we recommend and participate in the aca-
demic debate in a shared effort to establish EBP in P&O.
Results 
Methodological complexity in research on 
elderly amputee patients
In EBM, proofs of effectiveness of treatment are preferably 
assessed in clinical trials and its evidence summarized and 
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critically appraised in systematic reviews. Most systematic 
reviews judge research findings on a basis of a hierarchy 
of study designs, with randomized controlled trials (RCTs) 
at the top, producing the highest level of evidence, and 
case studies at the bottom, producing the lowest level of 
evidence. RCTs are placed on the top of the hierarchy, as 
they are best suited to rule out threats to internal validity. 
Therefore, RCTs are preferably carried out on homogene-
ous populations of adult patients who are preferably not 
older than 65 years and who have only the condition in 
question.18 Indeed, most research and clinical practice 
guidelines are based on a single-disease paradigm, which 
may not be appropriate for elderly patients with complex 
and overlapping health problems.19 Optimizing the care of 
older persons with multiple medical conditions is therefore 
a complex task, with clinicians receiving potentially con-
tradictory recommendations regarding how to tailor care 
for elderly from the medical literature.20 The majority of 
the patients in the field of P&O for whom clinicians need 
to make evidence-based decisions are also elderly with two 
or more morbidities such as diabetes and vascular dis-
eases.21,22 That introduces bias into data, which makes it 
difficult to get conclusive evidence for this complete target 
group. Excluding patients based on confounding factors 
such as multimorbidity results in a more homogeneous 
group and more conclusive results but at the same time 
limits the applicability of research findings for the com-
plete group. Therefore, exclusions made by researchers to 
prevent bias entering the research setting in order to pro-
duce methodological sound and generalizable results, do 
not resolve the complexity of the clinical decision process 
in prosthetic rehabilitation of older dysvascular amputee 
patients.
Although researchers in the field of P&O do recognize 
the complexity of the research in question, many of them 
continue to rely above all on the traditional study design 
hierarchy articulated in the EBM movement. Cumming 
et al.,21 for instance, concluded in their systematic review 
on older dysvascular amputee patients that more reliable 
evidence from high-quality and sufficiently powered RCTs 
on interventions is needed. They could include only one 
trial in their systematic review, a trial of which the meth-
odological quality was judged as moderate because of lack 
of power (only 10 patients), a missing description of the 
randomization, no intention to treat analysis, lack of point 
estimates and measures of variability presented for the 
primary outcome measures, and so on.21 The researchers 
explained that they conducted this study because they felt 
that the results of the previous studies on their research 
topic might not be directly attributable to the older less 
active poorly conditioned dysvascular amputees.23
Thus, researchers are urged to conduct high methodo-
logical quality in experimental settings (internal validity), 
on the one hand, and need to ensure applicability of the 
research findings for the wider population seen in clinical 
settings (external validity), on the other hand. A relative 
neglect of external validity in the EBP health literature is 
reported, which does have consequences for the relevance, 
generalizability and applicability of the research findings 
in varied circumstances in clinical settings.24 In the light of 
an ageing society, in which clinicians will face more and 
more older people with multimorbidity and multifaceted 
disabilities, there is an urgency to incorporate other research 
designs for this heterogeneous group. We therefore argue 
that researchers working in the field of P&O should 
reconsider traditional study design hierarchy, where 
appropriate, and explore other options like mixed methods 
research.
Mixed methods research can also provide high internal 
validity and at the same time offer the opportunity to deal 
with the heterogeneity of amputee characteristics. It 
involves the combination of two or more research designs 
having different strengths and not sharing the same 
biases.25 Often mixed methods research refers to the com-
bined use of both quantitative and qualitative methods, in 
which the researcher collects and analyses the data concur-
rently or sequentially, integrates the findings and draws 
inferences using both methods in a single study or pro-
gramme.26 In post hoc evaluations for instance, qualitative 
examination can identify why differences in intervention 
outcomes occurred, uncover additional treatment benefits 
and explore barriers to achieving the best intervention out-
comes.27 But the approach of mixed methods research can 
also encompass combining different qualitative methods 
such as in-depth interviews, focus-group discussions, doc-
umentary analyses or observations.9,28 Mixed methods 
research may thus assist in enhancing internal validity in a 
heterogeneous research population as well as balancing 
issues of internal and external validity. To our opinion, 
researchers in prosthetic rehabilitation could and should 
therefore profit from this ‘new’ research approach that can 
provide evidence that is better attuned to the variability of 
prosthetic rehabilitation and heterogeneity of the target 
group.
Impact of technological advancements on 
evidence-based prescription
Emerging technological advancements in prosthetics is 
another aspect that adds to the complexity in establishing 
EBP in P&O. Due to these advancements, clinicians face 
an overwhelming amount of available prosthetic compo-
nentry from which they have to choose.29 A problem is 
that empirical evidence on the surplus value of novel pros-
thetic componentry in relation to existing technologies 
comes quite some time after the innovations have been put 
on the market. Let us take the developing technology in 
prosthetic knee mechanisms as an example. Knee mecha-
nisms must provide stability and swing at appropriate 
rates to properly match an amputee patient’s ability.30 
Several orderings in available knee mechanisms can be 
distinguished.
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In the interviews, clinicians illustrated the impact of 
developing technology on their clinical decision process 
as follows; in former days, it was relatively simple: cli-
nicians and their patients could choose between several 
passive knee mechanisms comprising locked knee mech-
anisms and free swinging mechanisms. Interviewed clini-
cians elucidated that when they were in doubt about the 
most appropriate knee mechanism in former days, they 
chose a manual locked knee mechanism because of its 
safety. After prosthetic training, they could then decide 
whether a free swinging knee mechanism was optional for 
the longer term. With the invention of, for example, stance 
and swing phase control techniques, free swinging knee 
mechanisms got more and more sophisticated. These 
novel mechanisms became applicable for a wider variety 
of patients. For the clinicians in the local setting, this led 
to an actual shift in the prescription of prosthetics. They 
reported that nowadays they mostly select a free swinging 
mechanism with stance-control technique, and when that 
does not work out well, they can still choose a locked 
knee mechanism. The clinicians rationalized their choice 
for this sequence by arguing that it fits the learning strat-
egy that patients use to incorporate the mechanism of the 
prosthesis in their movements. They argued that it is very 
hard for a patient to unlearn a ‘stable’ movement pattern 
A (locked mechanism) and learn movement pattern B 
(free swinging mechanism) that is far more unstable. That 
is why they now often choose to start with the free swing-
ing mechanism.
For elderly dysvascular amputee patients, however, 
issues like muscle weakness, loss of coordination and bal-
ance are common additional conditions. Therefore, patient 
safety is a primary concern for clinicians.31 With the incor-
poration of several electronic control systems into pros-
thetic knee mechanisms, the range of available knee 
mechanisms is again broadened.32 In these active controlled 
knee mechanisms, microprocessors direct the knee’s resist-
ance to flexion and extension, thereby influencing a user’s 
ability to ambulate safely and/or effectively.31
Most interviewed clinicians, however, clarified that they 
barely prescribed microprocessor controlled knee mecha-
nisms (MKMs) for the older transfemoral amputee patients. 
They felt that most of these prostheses were developed for 
younger, more active patients. Nonetheless, there were also 
clinicians who pointed to advantages: that is, MKMs might 
require less cognitive demand for older amputee patients, 
who find it in general harder to conduct dual tasks. This 
might attribute to the safety of their functioning. But even 
then, prescription of MKMs remains a complex activity. 
The interviewed clinicians reported that the relative high 
costs of MKMs lead to resistance by health insurers. When 
they decided to take advantage of innovative technology in 
MKMs and prescribe a prosthesis with such a knee mecha-
nism for an elderly patient, health-care financers were not 
eager to pay for it.
Clinicians in prosthetic rehabilitation thus not only have 
to keep up-to-date with the technological advancements and 
fit its pros and cons in their prescription process, but they 
also have to take into account the interests of other stake-
holders such as the care financers of their patients. There is 
thus an urgent need for evidence in P&O: first, to support 
clinicians in making evidence-informed prosthetic prescrip-
tions for different target groups, and second, for grounding 
that prescription towards health-care financers. Lack of evi-
dence to support clinicians in the prescription process is 
indeed experienced as a huge barrier.21,33 In a meeting on 
the state of the evidence in P&O, the ‘science’ of P&O 
was even referred to as severely immature.34 The scientific 
literature on MKMs, for instance, showed mixed results 
on energy expenditure, gait performance and cognitive 
demand, while users’ satisfaction was globally positive. 
This is confirmed by a recent survey with prosthetists and 
orthotists, who also felt that research studies presented too 
many contradictory results, and what is more, the research 
findings were considered out of date.1 Contradictory 
research findings and various opinions about prescription of 
MKMs are among other things attributed to a lack of knowl-
edge on the exact target group for MKMs. Are the most 
technologically advanced prosthetic components only 
suitable for the young athletic amputees or can patients 
with a lower level of functioning also profit from this 
technology?31,35 The possibilities nowadays seem endless, 
but at the same time, clinicians in prosthetic rehabilitation 
are warned for too much optimism: when an individual is 
unable to ambulate with a nonmicroprocessor knee, there 
is little chance that he or she is able to ambulate and benefit 
from the features and functions of a MKM.36 More conserv-
ative components are often prescribed for patients with lim-
ited mobility, although several studies provided evidence 
that can counter this presumption.29,31
Therefore, advancements in technology certainly have 
an impact on clinical practice, and contradictory evidence 
on these advancements contributes to the complexity of 
EBP in P&O. Clinicians, researchers and designers are 
seen as important actors in this combined field of technol-
ogy, research and prosthetic rehabilitation. We therefore 
applaud initiatives that stimulate the multi-actor process in 
which all stakeholders combine their knowledge. Meetings 
in which clinicians, prosthetic users, researchers and 
prosthetic device manufactures37 or where prosthetists, 
orthotists, user representatives and research engineers34 
come together in order to attune their agendas on research 
projects on prosthetic technology are seen as promising 
examples.
Diverging classification systems in  
prosthetic prescription
Despite contradictory results and various opinions influ-
encing clinicians in their decision process, there are 
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evidence-based guidelines available for clinicians. These 
clinical practice guidelines for rehabilitation of lower-
limb amputation dedicate two subparagraphs to the pros-
thetic prescription phase. Clinicians are recommended to 
determine functional goals of prosthetic fitting (D1) and 
prescribe the prosthesis based on the current or potential 
level of ambulation (D2).17 To determine the potential 
level of functioning, the guidelines refer to the use of 
K-levels. K-levels stem from a coding system of the 
Health Care Financing Administration (HFCA), compris-
ing a 5-level functional classification system ordering the 
functional abilities of persons who have undergone lower-
limb amputation.38 This system was originally developed 
to assist a health-care insurance company (Medicare) 
with the decision which prosthetic components to cover 
but is now also incorporated in the guidelines to support 
clinicians in the prescription process. The K-level system 
can assist clinicians in selecting available componentry 
that is indicated for the specific K-levels. When a patient 
is resided in K-level 2, for instance, a prosthesis that 
meets the functional goals of limited community ambula-
tion is recommended (see Table 1).
The question, however, is how patients will be assigned 
to a certain K-level. Especially when taken into considera-
tion that patients are being evaluated on their potential, 
which could affect their future care as with Medicare 
patients. Therefore, it is important that what constitutes 
potential is standardized and measurable.39 The clinical 
guidelines nevertheless do not provide direction for this 
selection. It is again the clinician or the rehabilitation team 
that has to determine the skills and features of the patient 
and combine that with the desired level of participation of 
the patient. Therefore, this recommended classification 
system depends heavily on subjective procedures and 
clinical expertise of the rehabilitation team. The evidence-
based guidelines thus implicitly pass the responsibility to 
clinicians.
With the involvement of another stakeholder, the ortho-
paedic industry, the use of the classification system as a 
helpful instrument for clinical decision-making gets even 
more ambiguous. Certainly since providers, like Össur40 
and Otto Bock,41 present their own ‘unique’ classification 
systems on their websites. Otto Bock presents a classifica-
tion system that is named the MOBIS-Otto Bock mobility 
system with levels that are called ‘mobility grades’, and 
Össur presents a classification system with ‘impact lev-
els’. The four mobility grades of the MOBIS-Otto Bock 
mobility system resemble the K-levels 1–4, omitting 
K-level 0, as this indicates no prosthesis. Both the MOBIS-
Otto Bock system and the K-level system base their levels 
on the possibilities of the amputee to perform certain 
transfers, on which surface and with a certain kind of 
cadence. The impact levels of Össur, however, present 
ranges of activities and focus on the loading force (mini-
mal, moderate amount, high and extreme). The activities 
like shopping, gardening and household tasks are, for 
instance, linked to the low impact level. Although all three 
classification systems do have common features, they 
diverge in terminology and content. It is understandable 
that different industrial ventures wish to present their 
products as exclusive and therefore introduce their own 
‘unique’ classification system. Yet for clinicians who need 
to decide on prosthetic componentry, this leads to more 
unnecessary complexity. We therefore argue to further 
work in a joint manner on a more standardized classifica-
tion system that is attuned to the needs of clinicians and 
their patients.
Transfer to individual patients: additional 
modifying factors
The functional abilities as categorized in the classification 
system recommended by the guidelines are indeed not 
conclusive for the clinical decision process in the prescrip-
tion phase. Also physiological factors – including general 
health, weight, height, level of the amputation and length 
and shape of the residual limb – are to be considered when 
prescribing a prosthesis. According to the suppliers of 
prosthetic componentry, it is therefore not possible to offer 
an exact prescriptive tool online.40 In addition, also 
Table 1. Description of K-levels.
K-level 0 The patient does not have the ability or potential to ambulate or transfer safely with or without assistance, and 
a prosthesis does not enhance the quality of life or mobility.
K-level 1 The patient has the ability or potential to use a prosthesis for transfers or ambulation on level surfaces at fixed 
cadence. Typical of the limited and unlimited household ambulator.
K-level 2 The patient has the ability or potential for ambulation with the ability to transverse low-level environmental 
barriers such as curbs, stairs or uneven surfaces. Typical of the limited community ambulator.
K-level 3 The patient has the ability or potential for ambulation with variable cadence. Typical of the community 
ambulator who has the ability to transverse most environmental barriers and may have vocational, therapeutic 
or exercise activity that demands prosthetic utilization beyond simple locomotion.
K-level 4 The patient has the ability or potential for prosthetic ambulation that exceeds basic ambulation skills, exhibiting 
high impact, stress or energy levels. Typical of the prosthetic demands of the child, active adult or athlete.
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psychosocial factors need to be considered in the choice of 
componentry.
Interviewed clinicians emphasized within this context, 
the impact of fear of falling, which is present by many 
older amputee patients. According to them, a disabling 
fear of falling has a negative impact on autonomous move-
ment, which endangers safe functioning. Therefore, in 
order to succeed with the prosthetic fitting, elderly ampu-
tee patients must feel confident enough to deal with the 
knee mechanism.
The scientific literature, however, provides little insight 
into the predictive character of the different physiological 
and psychosocial factors. Therefore, also on these issues 
scientific knowledge is lacking to inform clinicians in 
prosthetic rehabilitation. Even of greater importance for a 
good prescription of prosthetic componentry are the wishes 
and preferences of patients themselves. Considering all the 
advancements in technology, it is necessary to examine 
what patients prefer. Several researchers have actually 
focused on the patients’ perspective on prosthetics includ-
ing the role of advancements in prosthetics.42–44 They 
expressed their concern that patients’ preference into the 
decision process lacks intention. They plead for standard-
ized methods in which to measure patient preferences 
within prosthetic prescription. In this technology-driven 
time frame in prosthetic rehabilitation, clinicians should be 
well aware of the patients’ psychosocial issues and patients’ 
emotions and feelings towards technological devices.43
These researchers42–44 thus impute an important role for 
clinicians in rehabilitation to balance the functional oppor-
tunities offered by technology with a holistic view on the 
patient. We argue that researchers themselves can also ful-
fil an important role in this balancing process. Combining 
several qualitative research techniques provides a fuller 
and deeper understanding of a certain issue.45 With the 
help of in-depth interviews individual perceptions, beliefs, 
feelings and experiences with prosthesis can be identi-
fied.28 Focus-group discussions can accordingly be used to 
gain in-depth understanding of the values of subgroups of 
patients and about the acceptance and use of certain pros-
theses, thereby comprising more comprehensive knowl-
edge on the issue. Researchers can provide clinicians in 
this way with in-depth knowledge about the grounds 
underlying articulated patients’ values and preferences by 
giving words to the voices of elderly patients and their car-
egivers in the field of P&O.
Explicating and comparing the tacit 
knowledge of clinicians working in P&O
There is not a simple recipe for prosthetic prescription that 
supports clinicians in the implementation process of EBP 
of lower-limb amputee patients in general and elderly dys-
vascular amputee patients in particular. The selection of the 
right componentry for a prosthesis cannot easily be made 
by summarizing and critical appraising available evidence 
in systematic reviews. To the contrary, clinicians do face a 
lack of evidence and when available contradictory results. 
On top of that, they have to deal with various classification 
systems, diverging interests of different stakeholders and 
many modifying factors, and all of this in a technological 
changing environment. In their search for an optimal pros-
thesis for individual patients, clinicians are thus confronted 
with many uncertainties and unidentified knowledge areas 
that contribute to the complexity of evidence-based pre-
scription in P&O. The rehabilitation team therefore relies 
for a great part on their own clinical experience to select 
the right prosthesis for an individual patient. In the indi-
vidual and focus-group interviews, clinicians described the 
prescription phase in this context as ‘an art’, ‘a sensitivity’, 
or ‘something speculatively’. Unfortunately, this so-called 
tacit knowledge is scarcely made explicit in prosthetic 
rehabilitation, which does not attribute to transparency in 
the field of P&O. This is a well-known problem and also 
seen in other fields. It is indeed acknowledged that it is dif-
ficult for clinicians in general to put the reasoning behind 
their decisions and actions into words.46,47 Clinical knowl-
edge is understudied and needs more articulation to make 
it transportable for sharing and thus for improvement.48 
How to profit from this area of clinical knowledge and 
expertise?
Participatory action research can be of great help in 
explicating this implicit knowledge of clinicians and can 
also be helpful in facilitating improvement. The participa-
tion part in participation action research implies that cli-
nicians are seen as partners in the research process, and 
the action part defines the commitment to change.28 
Participatory action research aims at (1) conducting 
research with people, not on people; (2) improving the 
situation and (3) learning and reflection between the 
researcher and researched.28 Researchers trained in par-
ticipatory action research can assist clinicians to make 
their implicit practical knowledge explicit with help of 
documentary analysis, observations of treatments, indi-
vidual and focus-group interviews and so on. By incorpo-
rating clinicians as partners in a research process, the 
researcher and clinicians can co-construct knowledge.49 
In a previous study,9 a participatory action research design 
helped us to collect, unravel and articulate tacit knowl-
edge of clinicians in prosthetic rehabilitation on specific 
issues, which was accordingly specified by asking clini-
cians to critically reflect on them in focus-group discus-
sions. Through this articulation process, we were able to 
identify the essential issues for improvement of the inter-
vention and its conceptual underpinnings in terms of 
problem-solving principles and practices.
Participation research, however, demands several skills 
of the researcher. To be able to articulate knowledge from 
an insider point of view (tacit knowledge of clinicians), 
researchers must have the skills to put themselves in the 
shoes of clinicians. From an outsiders point of view, they 
accordingly have to be able to put together the articulated 
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knowledge in conceptual frameworks developed to work 
on programme development.9,11,12 For example, they have 
to be able to specify systematically the treatment content 
(the features of the interventions, recipients and their 
environment) and its theoretical underpinnings. With this 
knowledge, treatment outcome research can be designed 
that can enhance both the understanding of research find-
ings and their usefulness in rehabilitation practice.11,12
We thus argue that participatory research provides depth, 
detail, nuance and context to EBP issues. Explicating the 
implicit knowledge of clinicians can contribute to a better 
understanding of clinical decision processes and can exam-
ine issues that are too complex to be easily disentangled by 
clinical epidemiological research. Integrating clinicians 
and patients in the research process involves recognizing 
the rights of those whom research concerns, enabling peo-
ple to set their own agendas for research and development 
and so giving them ownership over the process.13
Discussion
In this discussion paper, we have unravelled and explicated 
the problems that clinicians encounter when they want to 
implement the results of scientific research into practice of 
the P&O field. We focused on just one part of prosthetic 
rehabilitation, namely, the prosthetic prescription phase for 
older dysvascular transfemoral amputee patients and in 
particular on innovative technology of knee mechanisms. 
We illustrated that clinicians motivated to work on EBP in 
a lifelong manner not only need to handle a number of 
practical barriers in performing EBP but also have to be in 
accord with emerging technological advancements in this 
field50 and are on top of that asked to translate the collective 
and averaged body of external evidence (when available) 
to the individual needs of their patients.2 This means that a 
lot is asked from clinical and academic reasoning of clini-
cians in their effort to perform EBP. Certainly when taken 
into consideration that a prosthesis encompasses much 
more componentry than just a knee mechanism like ankle 
and foot mechanisms. All these mechanisms interact with 
each other, which increases the complexity of the prescrip-
tion of the right componentry.
We argued that it is a shared responsibility of both clini-
cians and researchers to deal with the complexity in P&O 
and rethink the relation between evidence, technology and 
rehabilitation practice. This implies that researchers have to 
learn to experiment with the many shades of grey designs 
that lie between black (case studies) and white (RCTs) 
designs, in order to provide scientific knowledge that will 
be better attuned to the complexity seen in clinical practice. 
Take the elderly dysvascular amputee patients, their multi-
morbidity and multifaceted disabilities indeed influence the 
linear relationship between experimental interventions and 
outcomes presumed in clinical trials thereby confounding 
research results. Adding qualitative research on the situated 
perceptions and experiences of the researched elderly will 
provide researchers with more detailed knowledge on the 
confounding factors. These findings will help them to place 
the quantitative data in perspective. It could be stated that 
in experimenting with the research designs, researchers 
also have to become lifelong learners, just like the clini-
cians, as was plead for in the culture change in P&O.3 It 
would even mean a culture change for funders, publishers 
and educators to enable, teach and support such research 
designs.
The role of clinicians in establishing EBP in P&O can 
also be seen in another light. Clinicians need to deal with 
several complex issues when they are asked to integrate 
individual clinical expertise and patient values with the 
best available evidence. This holds for rehabilitation medi-
cine in general and prosthetic rehabilitation for elderly 
dysvascular amputee patients in particular. To put it more 
encouragingly, it can also be said that clinical decision-
making in rehabilitation practice requires craftsmanship, 
creativity and pragmatic considering and assembling of all 
multifaceted aspects.16 Explicating this craftsmanship, 
creativity and resourcefulness, which clinicians make use 
of when dealing with the complexity, is of great impor-
tance. This is still a blind spot in rehabilitation research 
that does not do justice to the hard work of rehabilitation 
clinicians. The articulation of clinical practice as having a 
quality and logic of its own is a first step in the quest for 
more situated strategies for the improvement of rehabilita-
tion practice.16 Although there is the tradition of writing 
case reports and transferring clinical knowledge through 
medical education, researchers seldom reflect on clinical 
experience as a form of knowledge in itself. The practical 
knowledge of patients is even less studied and reflected 
on.48 It is therefore important to distinguish between evi-
dence-based knowledge produced in experimental set-
tings, clinical knowledge gathered by assessments and 
treatments of patients and practical knowledge from 
patients living with a condition or disease.
With this, we touch upon a more fundamental question 
being: is the term based in ‘EBP’ in this perspective an 
accurate term? If we argue that research evidence produced 
in experimental settings should not override, or take prec-
edence over, clinical experience, clinical embodied skills, 
patients’ needs, values and knowledge, then the relation-
ship between evidence and practice cannot be that of sup-
plying a basis for that very practice.9,15,51 It is of course 
important to critical appraise rehabilitation practices in 
experimental settings and conduct creative scientific inves-
tigations that may help to (im)prove it. But we suggest that 
all three knowledge practices, scientific knowledge from 
researchers, clinical knowledge from clinicians and practi-
cal knowledge from patients are important and should 
inform and strengthen each other. We therefore propose to 
replace the term based in EBP for informed. In evidence-
informed practice (EIP), clinicians are encouraged to be 
knowledgeable about the findings coming from all types of 
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scientific studies, and researchers are urged to support 
them in translating it to the local realities of different reha-
bilitation settings in an integrative manner.9,51 
Conclusion
Researchers should learn to take into consideration both 
articulated  clinical experiences and judgments, clients’ 
preferences and values, context of intervention and rele-
vant evidence produced in experimental settings and help 
clinicians to attune it to each other. In our opinion, EIP 
acknowledges both the crucial role and craftsmanship of 
the clinician and the researcher in providing the knowledge 
for the performance of optimal patient care in prosthetic 
rehabilitation.
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